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There has been considerable interest in the examination of reticuloendothelial system
phagocytic blockade. In this study, the kinetics of phosphobipid liposome-mediated and
intraperitoneal silica-mediated phagocytic blockade were examined using five methods
of analysis of in vivo mTc-babeIed albumin clearance and reticuboendothelial cell uptake.
Two direct blood sampling techniques revealed significant impairment in mTclabeled
albumin clearance after treatment with silica (P < 0.05), while Iiposome treatment was not
associated with such impairment. A method utilizing nuclear scintigraphy for the deter-
mination of blood clearance was incapable of detecting silica-mediated blockade but
demonstrated significant impairment by biposomes at 2 hr (P < 0.001), 6 hr (P < 0.05), and
24 hr (P < 0.001). Gamma camera Imaging methods for determination of hepatic uptake
demonstrated significant (P < 0.05) and reversible impairment of mTc-labeIed albumin
uptake by liposomes. The most promising of these techniques utilizes deconvolutional
analysis of liver region of interest time-activity curves to correct for continuously chang-
ing blood concentrations of tracer and for intracellular tracer processing and catabolism.
Measurements of reticuboendothelial system phagocytic activity should include methods
that take into account the observed discrepancies between blood clearance determina-
tions and reticuloendothelial cell uptake.
Key words: deconvolutionab analysis, reticuboendothelial blockade, silica, liposomes,
phosphobipid vesicles, endocytosis
INTRODUCTION
The reticuloendothelial system (RES), consisting of
fixed macrophages of the liver, spleen, lungs, and bone
marrow, provides the host with a variety of immunolog-
ical defenses including protection against infection, neo-
plasia surveillance, and recognition of foreign antigens
[5, 17]. This last function of processing antigens en-
hances the host’s capacity to reject allogeneic tissue and
organ transplants, and has stimulated interest in suppres-
sion of the RES to modulate the rejection of transplanted
organs.
Silica, a macrophage toxin, is one of the best studied
agents for inducing RES blockade. Levy and Wheelock
have shown that intravenous silica significantly de-
presses the clearance of colloidal carbon by the RES in
treated animals by destroying, rather than saturating RES
macrophages [1 1] . Furthermore, the toxicity observed
was specific to the fixed macrophages of the RES, as the
number of viable peritoneal macrophages was the same
in silica-treated and control mice. Silica was also shown
to have indirect effects on host immunity due to inter-
ruption of the immune cascade that is initiated by factors
released by macrophages. However, the usefulness of
silica in studying RES function is limited due to its sys-
tematic toxicity, the 2-3 day period required for its ef-
fects on RES function, and the fact that its effect may be
permanent [11, 12].
Liposomes are phospholipid vesicles formed when
water-insoluble polar lipids are confronted with water
[6]. They can exist in a variety of forms depending on
their method of preparation. Reverse phase evaporation
vesicles (REVs) are large unilamellar liposomes in which
a single lipid layer surrounds a large internal aqueous
space. Sonicated unilamellar vesicles (SUVs) are small
unilamellar liposomes in which a single lipid layer sur-
rounds a small aqueous space. Multilamellar vesicles
(MLVs) are large liposomes consisting of a series of
concentric layers of lipid, each separated by an aqueous
layer [8, 22]. As can be inferred, the ratio of lipid to
entrapped volume is considerably higher in both MLVs
and SUVs than in REVs.
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Initially, liposomes showed promise as a highly spe-
cific delivery system for various therapeutic agents. By
varying the composition of the phospholipid shell, the
vesicles could be targeted for specific tissues. Further-
more, they could be used to deliver a wide variety of
agents due to the presence of both aqueous and lipid
moieties. Early studies using liposomes, however, dem-
onstrated avid uptake of the vesicles by phagocytic cells
of the RES [8, 10, 24]. Kao and Juliano found that an
important mechanism of REV removal from the circula-
tion involved uptake by the phagocytic cells of the RES
[10] . When animals pretreated with a loading dose of
REVs were injected with radiolabeled REVs, the half-
life of the test dose particles was extended in the circu-
lation [10]. This is similar to the behavior exhibited by
liposomes injected in animals with RES blockade in-
duced by dextran sulphate and carbon [20], suggesting
that pretreatment with liposomes induces RES blockade.
This blockade appeared to be a result of the saturation of
the uptake capacity of the cells of the RES.
Further investigation of the interaction of liposomes
with the RES showed that liposome-induced blockade
was reversible and was dependent on the type of lipo-
some used [4, 19]. Ellens et al. showed that pretreatment
of animals with REVs caused a depression of RES func-
tion, as measured by the blood clearance rate of intrave-
nously injected carbon [4]. SUVs, however, did not
block RES activity, and the clearance rate of carbon at 1
hr after injection of the vesicles actually increased. Fur-
thermore, 24 hr after injection of REVs, the rate of car-
hon clearance returned to control levels, indicating that
liposome-mediated blockade of the RES diminished,
probably as a result of the vesicles being metabolized by
the phagocytes. The difference in clearance rate between
REVs and SUVs was attributed to the fact that large
liposomes are cleared more quickly than small ones [9].
Thus, the total amount of lipid taken up by the RES after
injection of equal doses will be larger with REVs,
thereby resulting in greater saturation of phagocytic ca-
pacity.
Safe and accurate in vivo measurement of RES phago-
cytic properties requires the use of a particle that is rap-
idly removed from vascular circulation and ingested by
cells of the RES, that measures -- 1 i.m, that has a nar-
row size distribution, that can be labeled with short-lived
radionuclides immediately before use, and that consists
of an organic, nonantigenic substance that is metaboliz-
able [3, 18]. Albumin millimicrospheres have been
shown to satisfy the above criteria [ 1 , 7 , 1 8] . Bolognesi
et al. found that 99mTclabeled albumin millimicro-
spheres form a tracer that is removed by the RES, mak-
ing it possible to calculate the maximum clearance rate of
the RES [ 1 ] . Since the macrophages of the liver and
spleen manifest approximately 85-95% of RES ac-
tivity, the clearance rate has been taken to be a measure
of RES phagocytic function [ 17].
In the current study, we attempted to determine the
kinetics of liposome- and silica-mediated effects on RES
phagocytic activity in an in vivo rat model by measuring
blood clearance and tissue distribution of a radiolabeled
albumin colloid. In particular, we compared five meth-
ods of data acquisition and analysis to evaluate quanti-
tative and qualitative differences among methods and to
demonstrate whether specific mechanisms of RES




Quartz silica particles (Sigma) were suspended in sa-
line (20 mg/mI) and subjected to ultrasonic vibration for
30 mm prior to injection. Injections of 50 mg/kg or 500
mg/kg were administered via the intraperitoneal (i.p.)
route 3 days prior to RES measurement.
Liposomes
REVs were prepared according to the method of Szoka
and Papahadjopoulos [22]. Briefly, a 5:4: 1 molar ratio of
cholesterol (Sigma), phosphatidyl-DL-glycerol (Sigma),
and dipalmitoyl-L-a-phosphatidyl-DL-choline (Sigma)
was dissolved in chloroform and evaporated to a thin dry
film in a round-bottomed flask on a rotary evaporator.
The film were redissolved in ether, and an aqueous phase
of phosphate-buffered saline (PBS) was added. This
mixture was then placed in a bath sonicator for 30 mm.
The resulting homogeneous mixture was reevaporated on
the rotary evaporator to achieve a frothy gel followed by
a free-running lipid. Doses of 20 mg/kg were injected
intravenously (i.v.) via the tail vein 2, 6, or 24 hr prior
to RES measurement. Prepared liposomes were stored,
following a nitrogen purge, at 4#{176}Cfor a maximum of 48
hr before injection.
Animals and Pretreatment Protocols
Adult male Sprague-Dawley rats (Charles River)
weighing 200-400 g were used. The experimental de-
sign was approved by the University of Michigan Com-
mittee on Use and Care of Animals, and uniform stan-
dards of animal care were followed as per the guidelines
established by the University of Michigan Unit for Lab-
oratory Animal Medicine. Animals were anesthetized
during experimentation with sodium pentobarbital (75
mg/kg i.p.). Animals were randomly assigned to six
groups. Group I served as control and was given 1 nil
sterile PBS i.v. via the tail vein, 1 hr prior to measure-
ment of RES function. Animals in groups 2 and 3 were
treated 3 days before measurement with silica 50 mg/kg
62 Goyal et al.
and 500 mg/kg i.p. , respectively. Animals in groups 4,
5, and 6 were given liposomes at a dose of 20 mg/kg i.v.
at 2, 6, and 24 hr before RES measurement, respec-
tively.
Measurement of RES Activity
Blood clearance and tissue distribution of 99fhTcla
beled colloidal albumin (Microlite, DuPont) were used
as monitors of RES phagocyte function. Following in-
jection of 1 mCi of the tracer via the penile vein, 50 il
blood samples were drawn from the tail vein at 1 mm
intervals for 10 mm and at 1 2 and 1 5 mm after injection.
Simultaneously, images were acquired by a gamma cam-
era (pinhole collimator with magnification) at 30 sec in-
tervals from 30 sec preinjection to 14 mm postinjection.
Five different methods were employed to analyze the
data. Methods 1 and 2 used blood clearance data. Sam-
ples were counted in a Packard Autogamma Scintillation
Spectrometer. Method 1 incorporated a log-linear regres-
sion by the least squares method, resulting in a biexpo-
nential function. The fast, early portion was stripped of
the late, slow portion of the plot to obtain the net slope
or clearance index (K) of the regression line from 2 to 5
mm [ 1 2] . Method 2 utilized a determination of the sim-
ple slope of a semilogarithmic plot of blood counts be-
tween 2 and 7 mm after injection [7].
Methods 3 through 5 utilized data obtained from the
gamma camera. Regions of interest were traced over the
liver and heart, and time-activity curves were processed
for each region of interest. Method 3 applied a log-linear
regression by least squares method on the data from the
gamma camera-generated liver region of interest counts
between 2 and 7 mm after injection to obtain a liver
uptake index (K) [7]. In method 4, the slope of a
semilogarithmic plot of the counts between 75 and 315
seconds from the heart region of interest was used to
approximate clearance of tracer from the blood (as in
method 1). Method 5 utilized a deconvolutional analysis
of gamma camera images over the liver region of interest
[23]. This technique allows for the measurement of he-
patic functions by simulating a bolus injection of the
tracer directly into the afferent blood supply of the liver
and corrects for the changing concentration of tracer in
the blood as it is extracted with each pass through the
liver.
Statistical Analysis
Descriptive data are expressed as mean ± SEM.
Slopes obtained by the various methods of analysis were
compared by the Kolmogorov-Smirnov two sample test,
using a P value less than 0.05 as the minimum level of
statistical significance.
RESULTS
The results of the five methods of data acquisition and
analysis in the six experimental groups are shown in
Table 1 . Using method 1 , high-dose silica administration
(group 3) resulted in a significant reduction in the rate of
blood clearance of the albumin colloid compared with
PBS-treated controls (group 1) (P = 0.023). The low
dose of silica (group 2) was associated with a reduction
in blood clearance compared with controls, but there was
a larger range of values obtained in group 2, and the
difference from control values did not achieve statistical
significance. Liposomes administered 2, 6, and 24 hr
(groups 3, 4, and 5, respectively) prior to determinations
by method 1 failed to demonstrate a significant reduction
of the clearance rate of radiolabeled albumin colloid
from blood.
Using method 2, in which analysis of blood clearance
data was restricted to the period of time between 2 and 7
mm after injection of the colloid tracer, both silica doses
resulted in significant reduction of RES ability to clear
blood of the albumin marker (P < 0.001). The low dose
of silica (group 2) was significantly more effective in
reducing blood clearance than the high dose (group 3) (P
= 0.023). Similar to method 1 , liposome administration
did not appear to affect blood clearance significantly as
measured by method 2. Both doses of silica produced
significantly more impairment of blood clearance capa-
bility than liposomes did at any time (P = 0.002) (Table
1).
In general, the gamma camera imaging acquisition and
analysis techniques produced more intragroup variability
than the direct blood clearance techniques (Table 1).
Method 3, which monitored hepatic uptake of tracer (as
opposed to blood clearance) was relatively insensitive to
the effects of the low dose of silica. The high dose of
silica actually resulted in a significantly enhanced he-
patic uptake of albumin tracer 72 hr after administration,
whereas uptake by the liver was significantly impaired 2
hr after administration of liposomes (P = 0.023). This
impairment by liposomes was reversed by 6 hr (P =
0.002 vs. 2 hr), and by 24 hr hepatic uptake was in-
creased over control animals in group 1 , although the
effect did not quite achieve statistical significance (P =
0.066) because of marked interanimal variability in
group 6 (Table 1).
Method 4 utilized gamma camera measurements of
blood clearance as determined by changes in counts ob-
tamed in a region of interest drawn over the heart. No
significant effect of silica at either dose compared with
control could be demonstrated by this method, whereas
liposomes administered at each of the three time points
prior to testing resulted in significant reduction in blood
clearance of the albumin tracer by gamma camera deter-
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aSee text for description of data acquisition and analysis methods.
mination. This contrasts to the results obtained by the
two direct blood sampling techniques (methods 1 and 2),
where no such effect of liposomes was seen (Table 1).
Some of this difference may be a result of inclusion of
left lung tissue in the gamma camera region of interest.
The final method of analysis utilized deconvolutional
analysis of hepatic region of interest curves generated by
method 3, adjusting for the continuously changing blood
concentration of tracer that is presented to the liver. Us-
ing method 5, silica effects on hepatic uptake were seen,
but did not achieve statistical significance. Hepatic up-
take was significantly increased 2 hr after liposome ad-
ministration (P = 0.002), but by 6 hr significant reduc-
tion in hepatic extraction was demonstrable (P =
0.023). This contrasts to the uncorrected results obtained
by method 3, which showed earlier impairment of he-
patic extraction and more rapid recovery. By 24 hr after
liposome treatment, hepatic albumin tracer extraction re-
turned to control values when measured by the decon-
volutional analysis technique.
DISCUSSION
The process of macrophage phagocytosis has been de-
scribed in terms of three distinct steps [16]. The initial
interaction of foreign particulate or antigenic material
consists of association of the particle with a macrophage
membrane receptor. This receptor may be specific or
nonspecific. Following adsorption, a surface-initiated
process of engulfment ensues, generally by endocytosis
[13]. Finally, once internalized, intralysosomal degrada-
tion of most foreign particles takes place [ I 6].
Normann has described the saturation kinetics of the
initial interaction with the macrophage membrane recep-
tor as being limited by the formation of an intermediate
colloid-membrane complex prior to internalization [13].
It appears that one type of colloid can competitively in-
hibit the interaction of another colloid with the mem-
brane, similar to competitive substrate inhibition in en-
zyme kinetics [ 14]. Two postulated mechanisms for
competitive inhibition include direct occupation of the
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membrane site preempting interaction by a second col-
bid moiety , or competition for opsonic molecules [ 13].
The latter appears to be unlikely in the face of evidence
that depletion of opsonins was not observed during lipo-
some-mediated RES blockade [4]. In other studies, dis-
similar particulate substances such as lipid emulsions,
iron, denatured albumin, and rabbit red blood cells were
capable of inhibiting phagocytosis of one another [ 14].
This implies that most substances undergo phagocytosis
through a process with at least some common pathways.
Finally, the observation has been made that impairment
of blood clearance is not necessarily attributable to dys-
function of the RES itself. The relative amounts of the
phagocytic blocking agent and the labeled test substance
may be an important factor in the appearance of blockade
by affecting access to the surface colloid-membrane
complex. By altering the ratio of putative blocking sub-
stance to test substance, RES blockade could be made to
appear or disappear, further substantiating the concept of
competition at the level of the colloid-membrane com-
plex [15].
The effects of silica on macrophage function have
been well studied [ 1 1 , 1 2] . As a direct toxin, intravenous
silica has been found to depress hepatic Kupffer cell
function profoundly, while peritoneal macrophages may
be less severely affected [1 1]. In previous studies, we
showed that intraperitoneal administration of silica re-
sulted in significant reduction of the clearance of 99mTc
labeled albumin millimicrospheres as well as decreased
hepatic uptake. These findings were again seen in the
current study, which utilized the more readily available
99’’Tc-labeled albumin colloid as a test substance. Using
two direct sampling blood clearance methods, high- and
low-dose silica resulted in a markedly reduced rate of
clearance of the radiolabeled albumin tracer from the
circulation. Unlike tissue distribution methods, which
rely upon total organ test substance uptake at a fixed time
point, the gamma camera imaging analysis used in
method 3 measured the dynamic appearance of radioac-
tivity over the liver region of interest over a defined
interval of time. The slope of the liver region of interest
curve was used to generate a liver uptake index. Low-
dose silica did not produce significant reduction of the
liver uptake index, while high-dose silica actually re-
suited in a slight but significant enhancement of hepatic
uptake. These findings may reflect membrane effects of
silica. Although blood clearance is impaired because of
membrane alterations produced by the silica, radiola-
beled albumin that successfully interacts at the colloid-
membrane interface may be phagocytosed at a more nor-
mal rate. Given these findings, it is difficult to explain
the discrepant results using analysis of gamma camera
images over the heart region of interest (method 4). No
impairment of clearance was seen using this method,
although the marked variation in results among the ani-
mals in this group leave open the possibility that the
failure to demonstrate significant blockade represents a
type II error. Method 5, which used deconvolutional
analysis of the liver region of interest images, also failed
to show significant blockade with silica. This technique
corrects the liver time-activity curve for confounding
factors such as the changing blood concentration of
tracer presented to the liver for phagocytosis and the
contribution of postphagocytic tracer processing and re-
circulation [23]. In contrast to method 3, which is un-
corrected for these factors, method 5 showed reduction
of the liver deconvolution index for both dose levels of
silica compared with controls. Although these differ-
ences did not achieve statistical significance, they sug-
gest that silica may affect macrophage-mediated particle
engulfment and internalization in addition to impairing
blood clearance by interfering with the rate-limiting in-
teraction of the test substance with the cell membrane.
Studies of the uptake and processing of liposomal
phospholipids by phagocytic cells have been previously
reported [2, 21]. Straubinger et al. have shown that neg-
atively charged liposomes are endocytosed by coated pits
in a manner analogous to other molecules that interact
with surface receptors [2 1] . Such liposomes appear to
associate rapidly with cells, saturating at approximately
l0 liposomes per cell. Once internalized, phospholipids
are degraded in isolated Kupffer cells [2] . It has been
suggested that acidification of the endocytosed vesicle,
rather than liposome fusion, results in the release of Ii-
posomal contents into the cytoplasm [21].
Kao and Juliano [ 10] made the important observation
that the RES might not constitute the only site or mech-
anism of liposomal clearance. As evidence for this as-
sertion, they showed that despite a substantial alteration
in the clearance rate of REVs after administration of
latex beads, there was not a major change in the tissue
distribution of the radiolabeled REVs. These studies did
not, however, specifically address the issue of phagocy-
tic rate, since saturation of the membrane interaction
producing reduced blood clearance might still allow for
the ultimate accumulation of control levels of liposomes
during the 2 hr incubation interval studied. Souhami et
al. [20] carefully studied the effect of blockade by dcx-
tran sulphate and carbon on liposome clearance and tis-
sue distribution. In contrast to Kao and Juliano’s work,
they found that blockade reduced both liposome clear-
ance and hepatic uptake, except in the cases of positively
charged large liposomes and neutral small unilamellar
vesicles, in which blockade produced delayed clearance
without altered liver uptake. These authors have postu-
lated that, in addition to Kupffer cells, other cells in the
liver such as sinusoidal endothelial cells and hepatocytes
must be capable of liposome uptake.
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Previous studies have shown that liposomes are capa-
ble of blocking the RES [ 1 2] , in some cases reversibly
[4]. The half-life of REVs after intravenous injection is
approximately 40 mm [ 10] , so that by the time the RES
studies are performed 2, 6, or 24 hr later the vast ma-
jority of liposomes will have disappeared from circula-
tion. In one study, REVs produced significantly reduced
blood clearance of 99mTclabeled albumin millimicro-
spheres for at least 1 8 hr after liposome administration
[12]. Ellens et al. [4] showed that the RES blockade
present 4 hr after dosing with liposomes was reversed by
24 hr. In the current study, REVs showed only modestly
reduced clearance by direct blood sampling techniques.
Measurements by gamma camera imaging over the heart
region of interest, however, demonstrated significant im-
pairment of tracer clearance as early as 2 hr after lipo-
some treatment, which persisted at 24 hr. Hepatic uptake
rates, in contrast to static tissue distribution studies,
yielded interesting results. Method 3 (crude hepatic up-
take index) appeared to demonstrate significant impair-
ment of hepatic RES function 2 hr after liposome admin-
istration, with recovery to control values at 6 and 24 hr.
The deconvolutional analysis technique utilized in
method 5 to evaluate gamma camera-generated hepatic
uptake yielded the clearest picture. This technique con-
tinuously corrects for the changing blood concentration
of the tracer substance that is presented to the hepatic
RES cells, allowing for more precise estimation of he-
patic RES kinetics. In this way, confounding factors
such as recirculation of tracer, changes in the intracellu-
lar metabolic processing of radiolabeled colloid, and the
release of free 99mTc after degradation of the colloid are
accounted for [23]. Additionally, prior studies of organ
distribution analysis after administration of 99’Tc-
labeled albumin have shown an 80-100-fold greater up-
take of tracer in the liver when compared with the spleen
or lung, reflecting the proportionally greater concentra-
tion of RES activity in the liver [18].
Using the deconvolutional technique (method 5), we
have demonstrated a statistically significant enhance-
ment of hepatic RES function 2 hr after liposome admin-
istration (P = 0.002 vs. control), significant blockade
by 6 hr (P = 0.023 vs. control; P = 0.002 vs. 2 hr
liposomes), and a return to baseline levels at 24 hr.
These results suggest that the process of liposomal phos-
pholipid-membrane complex interaction may transiently
increase overall phagocytic activity in the liver. Once
saturation of membrane receptors occurs, however, suf-
ficient quantities of liposomes may be associated with
the cell to impede this step in the phagocytic process.
Further, when a large enough quantity of endocytosed
lipid is present in the cell, the engulfment function may
also be overwhelmed until lipid metabolism and degra-
dation occurs. Finally, after sufficient time has passed,
the cell is again capable of phagocytosis at a normal rate
by the sequential process of association with the mem-
brane receptor followed by endocytic engulfment.
In conclusion, the data presented in this study indicate
that the method of analysis is a crucial factor in the
accurate estimation of RES function. A combination of
blood clearance and hepatic RES uptake analysis using
the technique of deconvolutional analysis appears to of-
fer the clearest picture of the dynamic process of in vivo
RES-mediated phagocytic function. This technique
avoids the limitations associated with the isolated use of
simple blood clearance techniques and the methodolog-
ical shortcomings ofpure time-activity curve generation.
Finally, this technique has the potential to offer new
insights into the in vivo association, uptake, and process-
ing of liposomes that are capable of reversible blockade
of hepatic RES phagocytic function.
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